Next-Generation Surgical Mesh System with Integrated Tissue Engineering

A novel surgical mesh system that incorporates nanotechnology-based tissue engineering, bioactive materials, and adaptive design to enhance tissue regeneration and improve patient outcomes in soft tissue defect repair.

The original segmented skirted surgical mesh patent addresses the need for reinforced soft tissue defects, but its design limitations restrict its ability to adapt to changing tissue dynamics and promote optimal tissue regeneration. The next-generation surgical mesh system overcomes these limitations by integrating advanced technologies to create a more effective and efficient solution.

The new surgical mesh system consists of a base layer of surgical mesh with an outer edge, a segmented skirt of surgical mesh with an outer edge and an inner edge, and a nanotechnology-based tissue engineering component integrated into the segmented skirt. This component enhances tissue regeneration by promoting cellular growth and differentiation. The system can be infused with bioactive materials that stimulate tissue growth and differentiation, and the segmented skirt is designed to adapt to changing tissue dynamics during the healing process. Additionally, the system can be modular, with interchangeable segmented skirts of varying geometries and material properties, allowing for real-time optimization based on tissue analysis and surgical goals. A robotic system can also be used to deploy and configure the mesh in a minimally invasive surgical procedure, ensuring optimal mesh configuration and placement.

The integration of nanotechnology-based tissue engineering, bioactive materials, and adaptive design elements in the surgical mesh system represents a significant departure from the original patent and provides a non-obvious solution to the problem of soft tissue defect repair.

Alternative embodiments of the inventive concept could include the use of different nanotechnology-based tissue engineering components, varying geometries and material properties of the segmented skirt, and different robotic systems for deployment and configuration. These variations would ensure broad conceptual coverage and adaptability to different surgical scenarios.

The next-generation surgical mesh system has significant commercial potential in the medical device industry, particularly in the areas of soft tissue defect repair, abdominal hernia repair, and tissue engineering. The system's ability to enhance tissue regeneration and improve patient outcomes could lead to widespread adoption and market growth.